MediciNova, Inc. (MNOV) Social Stream
Featured Post From StockTwits About MNOV
$MNOVSharmaji27, published August 12, 2021
10-Q key features
Pursue the development of MN-166 (ibudilast) with NON-DILUTIVE financings.
Pursue the development of MN-001 (tipelukast) for fibrotic and other diseases.
Consider strategic partnerships with one or more leading pharmaceutical.
Blackrock, vanguard and JPM increased their position significantly. JPM today by 222% more.
something cooking? Guess, time will say. Follow for more update